A new report by the Blue Cross Blue Shield Association has eye-opening findings about diabetes prevalence, severity and cost.
A real-world study of type 2 diabetes patients by Milliman has surprising findings on glycemic control and diabetes medication adherence.
Experts share updates on new diabetes medications, and provide an overview of what’s coming.
Find out about the latest treatment and drug pipeline developments
How much does diabetes cost the healthcare system and what's driving cost increases? Find out.
Here’s how remote monitoring works to improve diabetic patient care, and a look at whether payers are paying for it.
Studies have found that getting diabetes under control early on has immediate benefits. Here’s how providers and patients can more proactively address the disease.